Kestra Advisory Services’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
Other funds holding GMED
JT
SC
Kestra Advisory Services's GMED Position: Q2 2026 in Review
Kestra Advisory Services reduced its Globus Medical (GMED) stake by 1.9% in Q2 2026, selling an estimated $13.7K and leaving 8,483 shares worth $670K. The position accounts for ﹤0.01% of the portfolio, ranked #2101.
Kestra Advisory Services first reported a position in GMED in Q2 2022 and has held it in 8 quarters since. The position peaked at $749K in Q4 2025. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.
- Kestra Advisory Services held 8,483 shares of Globus Medical worth $670K as of Q2 2026.
- Kestra Advisory Services sold 161 Globus Medical shares in Q2 2026, an estimated $13.7K.
- Globus Medical made up ﹤0.01% of Kestra Advisory Services's portfolio in Q2 2026, its #2101 holding.
- Kestra Advisory Services first reported a position in Globus Medical in Q2 2022 and has held it in 8 quarters since.
- Kestra Advisory Services's Globus Medical position peaked at $749K in Q4 2025.
- 601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.
Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.